text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007933/2022

text: clinical

text: Baseline surveillance


status: PUBLIC

text: SARS-CoV-2: clinical or host-associated

tag: attribute

characteristic: BioSampleModel

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: pda|emily.smith@theiagen.com

characteristic: INSDC center alias

text: pda|emily.smith@theiagen.com

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: NCBI

characteristic: broker name

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

characteristic: host

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007934/2022

characteristic: isolate

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

characteristic: organism

text: Baseline surveillance

characteristic: title


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007935/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007937/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007938/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007939/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007940/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007941/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007942/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007943/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Butte CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007979/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007989/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007992/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007993/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007994/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007995/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007996/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007997/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000007999/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008000/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008001/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008002/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008003/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008004/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008005/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008006/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008007/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008009/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008010/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008011/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008012/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008013/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008014/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008015/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008016/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008017/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008018/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008019/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008020/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008021/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008022/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008023/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008024/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008025/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008026/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008027/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008028/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008029/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008030/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-72 Fresno

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008031/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-72 Fresno

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008032/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-72 Fresno

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008033/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-72 Fresno

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008034/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-72 Fresno

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008035/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-72 Fresno

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008036/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008037/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008038/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008039/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008040/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008041/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008042/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008043/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008044/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008045/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008046/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008048/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008049/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008050/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008051/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008052/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008053/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008054/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008055/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Joaquin CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008061/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Madera CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008068/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Mateo CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008077/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Bernardino CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008082/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Bernardino CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008083/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Bernardino CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008087/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008088/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008089/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008090/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008091/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008092/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008094/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008096/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-72 Fresno

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008097/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-72 Fresno

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008098/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-72 Fresno

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008099/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-72 Fresno

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008100/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Butte CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008104/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008105/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008106/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008107/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008108/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008109/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008110/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-61 Sac Med Cen

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008113/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-61 Sac Med Cen

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008114/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-61 Sac Med Cen

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008115/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-61 Sac Med Cen

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008116/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-61 Sac Med Cen

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008117/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-61 Sac Med Cen

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008118/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008120/2021

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008129/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008132/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Santa Cruz CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008134/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Santa Cruz CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008136/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Santa Cruz CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008137/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Santa Cruz CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008138/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Santa Cruz CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008139/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Santa Cruz CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008140/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Santa Cruz CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008141/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Santa Cruz CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008142/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Santa Cruz CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008143/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Santa Cruz CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008144/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Santa Cruz CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008145/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Santa Cruz CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008147/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008148/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008149/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008151/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008161/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008165/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008167/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008175/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008176/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008178/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008179/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008180/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008181/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008183/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008184/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008185/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008186/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008187/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008188/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008189/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008191/2021

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008192/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008193/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008194/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008195/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008196/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008198/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-61 Sac Med Cen

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008199/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008200/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008201/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008202/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Butte CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008282/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Butte CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008283/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Butte CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008285/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008290/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008291/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-57 Deer Valley

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008292/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-57 Deer Valley

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008293/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-57 Deer Valley

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008294/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Placer CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008346/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Placer CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008348/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Placer CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008350/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Placer CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008351/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Placer CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008355/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Placer CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008357/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Placer CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008361/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Placer CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008363/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008364/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008365/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008366/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008367/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Butte CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008370/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Butte CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008371/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Butte CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008372/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Butte CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008373/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Butte CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008374/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Butte CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008377/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Bernardino CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008378/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Bernardino CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008381/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Bernardino CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008389/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Madera CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008397/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008412/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-57 Deer Valley

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008420/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-57 Deer Valley

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008421/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-57 Deer Valley

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008422/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-57 Deer Valley

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008423/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-57 Deer Valley

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008424/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-57 Deer Valley

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008425/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-57 Deer Valley

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008426/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-57 Deer Valley

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008427/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-57 Deer Valley

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008428/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-21 Vallejo

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008429/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-72 Fresno

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008430/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008431/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008432/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008433/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-12 Richmond

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008434/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008435/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-12 Richmond

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008437/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008438/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008439/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008440/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-85 Modesto

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008441/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Kaiser Regional-59 Roseville

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008447/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Fresno CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008451/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Merced CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008461/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Mateo CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008468/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Mateo CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008474/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Mateo CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008475/2021

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Mateo CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008476/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Mateo CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008477/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Mateo CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008478/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Mateo CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008481/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Mateo CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008489/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Mateo CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008491/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Mateo CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008493/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Mateo CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008505/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Mateo CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008538/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Fresno CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008548/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008549/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008550/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008551/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008552/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008553/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008554/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008555/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008556/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008557/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008558/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008559/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008560/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008561/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008562/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008563/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008564/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008565/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008566/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008567/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008568/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: San Francisco CHD

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008569/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008614/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008615/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008616/2021

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008617/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008618/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008619/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008620/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008622/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008623/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008625/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008626/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008627/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008628/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008629/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008630/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008632/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008633/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008634/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008635/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008731/2021

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008732/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008733/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008734/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008735/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008736/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008737/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008738/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008739/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008740/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008742/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008743/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008744/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008745/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008746/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008749/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008750/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008751/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008752/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008753/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008754/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008755/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008756/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008757/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008758/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008759/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008761/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008762/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008763/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008764/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008765/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008767/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008768/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008769/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008770/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008771/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008772/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008773/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008775/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008776/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008777/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008778/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008779/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008780/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008781/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008783/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008784/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008785/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008786/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008787/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008788/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008789/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008791/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008792/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008793/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008794/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Valley Children

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-6000008795/2022

text: clinical

text: Baseline surveillance